Skip to content


Somapharm introduces itself –
Basic information Investor Relations

Who we are

  • Somapharm is a leading provider of medical products in Switzerland.
  • Somapharm can look back more than 25 years of successful sales in the medical industry.
  • Somapharm has already successfully positioned several revolutionary products in the field of brain surgery, setting new standards.
  • Somapharm offers a variety of products for clinics and medical practices, and primarily advises surgical departments on the introduction of new applications.
  • Somapharm's customers include the most important clinics in Switzerland, including the university hospitals: Zurich, Berne, Basel, Lausanne, Geneva, the Hirslanden Group, almost all cantonal hospitals and a number of medical practices and private institutions.

Our aim

  • Somapharm sets new standards in mobile medicine and stands for portability in healthcare.
  • Somapharm increases patients' chances with the best possible on-site infrastructure.
  • Somapharm enables new, immediate life-saving measures for doctors and rescue teams.
  • Somapharm makes medicine more accessible and economical on a global scale.
  • Somapharm decentralises hospitals, thereby reducing healthcare costs.

What we offer

  • Somapharm stands for stability through its business model and many years of experience.
  • Somapharm provides security through a very prudent, but proven, business strategy.
  • Somapharm generates above-average and sustainable returns in the healthcare sector.
  • Somapharm is a commitment to the future of mobile and portable medicine.
  • Somapharm offers experienced management and a business model that has already been proven.

Switzerland's medical technology industry





0 Mrd.


0 Mrd.



  • The growth trend of recent years could thus be continued. Over the past six years, the MedTech industry has posted constant sales growth of around 6% per year.
  • The growth achieved is above that of Switzerland's GDP in previous years (1.7% in 2016, 1.8% in 2017 and 2.8% in 2018)
  • The Swiss MedTech industry exported a volume of 11.3 billion in 2017. This represents 5.1% of total Swiss exports.

Sie wünschen weiterführende Informationen?


Der erste Eindruck zählt


Somapharm brachte in den vergangenen Jahrzehnten immer wieder exzellente Produkte auf den Markt und sorgt für Nachhaltigkeit in ihrem Geschäftsbereich.

Prof. Dr. A. Mendelowitsch, Hirslanden Gruppe

Sowohl im Vertrieb, als auch im Bereich von erfolgreichen und nachhaltigen Produktentwicklungen hat sich die Somapharm über die Jahre einen Namen gemacht der für Zuverlässigkeit, Innovation und Kundenservice auf höchstem Niveau steht.

Dr. med. T. Feuerstein, FMH Neurochirurgie

Die Somapharm ist für uns eine sehr professionell organisierte und effektive, kundennah operierende innovative Firma, die über eine exzellente technische klinische Produktpalette verfügt.

A. Züger, Medizintechniker

Unsere Kunden